Found: 11
Select item for more details and to access through your institution.
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
- Published in:
- 2020
- By:
- Publication type:
- editorial
The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Erice Call for Change: Utilising Patient Experiences to Enhance the Quality and Safety of Healthcare.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Benzodiazepine Use and Risk of Acute Angle-Closure Glaucoma: A Population-Based Case-Crossover Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Fluoroquinolone-Induced Photosensitivity: A Chemical Fragment-Based Approach by a Case/Non-case Study in VigiBase<sup>®</sup>.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.
- Published in:
- Drug Safety, 2020, v. 43, n. 6, p. 583, doi. 10.1007/s40264-020-00925-4
- By:
- Publication type:
- Article
Patterns of Inpatient Antibiotic Use Among Public Hospitals in Hong Kong from 2000 to 2015.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS).
- Published in:
- 2020
- By:
- Publication type:
- letter